Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating expenses:
Research and development	$ 58,060,725	$ 70,244,579	$ 53,647,067
General and administrative	66,646,205	28,896,749	13,598,030
Total operating expenses	124,706,930	99,141,328	67,245,097
Loss from operations	(124,706,930)	(99,141,328)	(67,245,097)
Interest and amortization of debt discount expense	(5,696,062)	(2,565,838)	(1,239,537)
Tax credit		53,578	139,448
Loss on extinguishment of debt		(1,247,012)
Net loss	$ (130,402,992)	$ (102,900,600)	$ (68,345,186)
Net loss per common share, basic and diluted	$ (3.47)	$ (2.77)	$ (2.01)
Weighted average common shares outstanding, basic and diluted	37,618,599	37,206,928	34,020,257